Home » Topics » Deals and M&A » Collaboration

Collaboration
RSS

Pfizer issues milestone payment to MorphoSys regarding phase I testing of HuCAL-derived antibody

Jan. 31, 2011

Bayer and Zydus Cadila form joint company in India to optimize product portfolios

Jan. 31, 2011

Soligenix and University of Colorado enter agreement for thermostable vaccines

Jan. 31, 2011

Actelion and GSK discontinue phase III development of almorexant

Jan. 28, 2011

Mitsubishi Tanabe Pharma and Nycomed terminate roflumilast collaboration in Japan

Jan. 28, 2011

UMMS and Lundbeck to codevelop targeted RNAi therapy for Huntington's disease

Jan. 28, 2011

Endo Pharma and Orion enter into oncology collaboration

Jan. 28, 2011

ALK-Abello and Torii Pharma enter license agreement for allergy immunotherapies

Jan. 28, 2011

NuVax licenses immune-gene therapeutics technology

Jan. 28, 2011

Sunshine Biopharma and Binghamton University sign agreement for Adva-27a

Jan. 27, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
New evidence links autoimmunity to long COVID symptoms
BioWorld
Recent findings are reshaping current understanding of the post-infection landscape of SARS-CoV-2. Although previous studies had already suggested that...
Will Ovid’s golden age of KCC2 metamorph CNS?
BioWorld
The “deep dive” April 8 by Ovid Therapeutics Inc. into potassium-chloride co-transporter 2 (KCC2) research included company officials and independent experts in...
BMS-Hengrui deal strikes panic in Washington
BioWorld
On the heels of the multibillion-dollar licensing deal between Bristol Myers Squibb Co. and Jiangsu Hengrui Pharmaceuticals Co. Ltd., Chairman John Moolenaar...